Li, L., Rojiani, A. M. and Siemann, D. W. (2002) “Preclinical Evaluations of Therapies Combining the Vascular Targeting Agent Combretastatin A-4 Disodium Phosphate and Conventional Anticancer Therapies in the Treatment of Kaposi’s Sarcoma”, Acta Oncologica, 41(1), pp. 91–97. doi: 10.1080/028418602317314127.